Literature DB >> 19841888

Using individual patient data in meta-analyses of glucose-lowering studies.

J S Yudkin, B Richter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19841888     DOI： 10.1007/s00125-009-1564-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Intensive glucose control and cardiovascular outcomes.

Authors:  John S Yudkin; Bernd Richter
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

3.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

4.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

5.  Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Authors:  F M Turnbull; C Abraira; R J Anderson; R P Byington; J P Chalmers; W C Duckworth; G W Evans; H C Gerstein; R R Holman; T E Moritz; B C Neal; T Ninomiya; A A Patel; S K Paul; F Travert; M Woodward
Journal:  Diabetologia       Date:  2009-08-05       Impact factor: 10.122

6.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

Authors:  Rachel A Whitmer; Andrew J Karter; Kristine Yaffe; Charles P Quesenberry; Joseph V Selby
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

9.  Patient perceptions of quality of life with diabetes-related complications and treatments.

Authors:  Elbert S Huang; Sydney E S Brown; Bernard G Ewigman; Edward C Foley; David O Meltzer
Journal:  Diabetes Care       Date:  2007-07-10       Impact factor: 19.112

10.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

Authors:  Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; Shanelle Wijesuriya; Rupa Sivakumaran; Sarah Nethercott; David Preiss; Sebhat Erqou; Naveed Sattar
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321
View more
  1 in total

1.  Intensive glucose control and macrovascular outcomes in type 2 diabetes. Reply to Emanuele NV [letter] and Yudkin JS, Richter B [letter].

Authors: 
Journal:  Diabetologia       Date:  2009-11-12       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.